Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats

Theta (theta) rhythm may be mediated, at least in part, by a glutamate neurotransmitter. Thus, in the present study, it was hypothesized that the septum glutamatergic NMDA receptor subtype may be involved in the modulation of physostigmine-induced theta rhythm. To test this hypothesis, we analyzed,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental brain research 1996-06, Vol.109 (3), p.384-392
Hauptverfasser: Puma, C, Monmaur, V, Sharif, A, Monmaur, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 392
container_issue 3
container_start_page 384
container_title Experimental brain research
container_volume 109
creator Puma, C
Monmaur, V
Sharif, A
Monmaur, P
description Theta (theta) rhythm may be mediated, at least in part, by a glutamate neurotransmitter. Thus, in the present study, it was hypothesized that the septum glutamatergic NMDA receptor subtype may be involved in the modulation of physostigmine-induced theta rhythm. To test this hypothesis, we analyzed, in the urethane-anesthetized rat, the effects of septum application of NMDA and D-2-amino-5-phosphonopentanoic acid (AP5), selective and competitive NMDA agonist and antagonist, respectively, on the spectral characteristics of hippocampal theta rhythm elicited by intravenous injection of a anticholinesterase agent, physostigmine. A low dose (16 nmol) of AP5 did not significantly affect EEG recordings, whereas a high dose (50.75 nmol) resulted in significant decreases in phase (-61.8%) at theta frequency, peak theta power (-64.2%), and absolute power of the low-frequency theta band (-67%). These electroencephalographic alterations, which appeared at 50.75 nmol AP5, were amplified following application of massive doses of the drug (121.8 nmol, n = 1, and 162 nmol, n = 1). Amplification, however, was slight and the theta waves remained clearly detectable. On the other hand, the infusion of NMDA resulted in a significant increase in frequency (+25%) of this rhythm, but this effect was completely antagonized by prior local administration of 16 nmol AP5. Our data suggest that the septal NMDA receptors exert subtle modulatory influences on the septohippocampal cells involved in physostigmine-induced theta wave production, which has not been reported elsewhere: tonic with respect to both low-frequency theta band power and theta phase, and phasic with respect to theta frequency. Our data also indicate that the septum may be a sensitive action site for exogenously administered glutamatergic drugs.
doi_str_mv 10.1007/BF00229622
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15778574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15778574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-a94d28e2890efd1fccd16f968d913a3235ef27fe4f94c242a6177facf06230a83</originalsourceid><addsrcrecordid>eNpFkU9v1DAQxS0EKkvhwh3JJw5IBv_JJs6xtBQqteUC52hwxhujxDa2g7R8ab4C3nZpDyNr7N-8edYj5LXg7wXn3YePl5xL2bdSPiEb0SjJhODtU7LhXDSs0aJ_Tl7k_PPQqo6fkBOtRSdbvSF_r3xJkDEWmKnzds0ueBoszTijKe43UvAjNWGJWNxdv5vXAgsUpAlNHQyJwi54lwu9vbk4u-PBl_93F0wyWJwPbMviFHItHyJWwAdnKBg30hzrrnRwsMTZGSjVRKa2KpcJaZz2OeTidlUFmfPjanCkk4sxGFhiHatUAZqmfZmW-gu6JiwTVLhWPjy6P3UiQckvyTMLc8ZXx_OUfL_89O38C7v--vnq_OyaGSVUYdA3o9Qodc_RjsIaM4rW9q0ee6FASbVFKzuLje0bIxsJreg6C8byVioOWp2St_e6MYVfazUxLC4bnOfqKKx5ENuu09uuqeC7e9CkkHNCO8TkFkj7QfDhkO7wmG6F3xxV1x8Ljg_oMU71D02pp1M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15778574</pqid></control><display><type>article</type><title>Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats</title><source>MEDLINE</source><source>SpringerLink Journals (MCLS)</source><creator>Puma, C ; Monmaur, V ; Sharif, A ; Monmaur, P</creator><creatorcontrib>Puma, C ; Monmaur, V ; Sharif, A ; Monmaur, P</creatorcontrib><description>Theta (theta) rhythm may be mediated, at least in part, by a glutamate neurotransmitter. Thus, in the present study, it was hypothesized that the septum glutamatergic NMDA receptor subtype may be involved in the modulation of physostigmine-induced theta rhythm. To test this hypothesis, we analyzed, in the urethane-anesthetized rat, the effects of septum application of NMDA and D-2-amino-5-phosphonopentanoic acid (AP5), selective and competitive NMDA agonist and antagonist, respectively, on the spectral characteristics of hippocampal theta rhythm elicited by intravenous injection of a anticholinesterase agent, physostigmine. A low dose (16 nmol) of AP5 did not significantly affect EEG recordings, whereas a high dose (50.75 nmol) resulted in significant decreases in phase (-61.8%) at theta frequency, peak theta power (-64.2%), and absolute power of the low-frequency theta band (-67%). These electroencephalographic alterations, which appeared at 50.75 nmol AP5, were amplified following application of massive doses of the drug (121.8 nmol, n = 1, and 162 nmol, n = 1). Amplification, however, was slight and the theta waves remained clearly detectable. On the other hand, the infusion of NMDA resulted in a significant increase in frequency (+25%) of this rhythm, but this effect was completely antagonized by prior local administration of 16 nmol AP5. Our data suggest that the septal NMDA receptors exert subtle modulatory influences on the septohippocampal cells involved in physostigmine-induced theta wave production, which has not been reported elsewhere: tonic with respect to both low-frequency theta band power and theta phase, and phasic with respect to theta frequency. Our data also indicate that the septum may be a sensitive action site for exogenously administered glutamatergic drugs.</description><identifier>ISSN: 0014-4819</identifier><identifier>EISSN: 1432-1106</identifier><identifier>DOI: 10.1007/BF00229622</identifier><identifier>PMID: 8817268</identifier><language>eng</language><publisher>Germany</publisher><subject>2-Amino-5-phosphonovalerate - pharmacology ; Anesthetics, Intravenous ; Animals ; Electroencephalography - drug effects ; Excitatory Amino Acid Agonists - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Hippocampus - drug effects ; Hippocampus - physiology ; Male ; Microinjections ; N-Methylaspartate - pharmacology ; Physostigmine ; Rats ; Rats, Wistar ; Septal Nuclei - drug effects ; Septal Nuclei - physiology ; Theta Rhythm - drug effects ; Urethane</subject><ispartof>Experimental brain research, 1996-06, Vol.109 (3), p.384-392</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c313t-a94d28e2890efd1fccd16f968d913a3235ef27fe4f94c242a6177facf06230a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8817268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Puma, C</creatorcontrib><creatorcontrib>Monmaur, V</creatorcontrib><creatorcontrib>Sharif, A</creatorcontrib><creatorcontrib>Monmaur, P</creatorcontrib><title>Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats</title><title>Experimental brain research</title><addtitle>Exp Brain Res</addtitle><description>Theta (theta) rhythm may be mediated, at least in part, by a glutamate neurotransmitter. Thus, in the present study, it was hypothesized that the septum glutamatergic NMDA receptor subtype may be involved in the modulation of physostigmine-induced theta rhythm. To test this hypothesis, we analyzed, in the urethane-anesthetized rat, the effects of septum application of NMDA and D-2-amino-5-phosphonopentanoic acid (AP5), selective and competitive NMDA agonist and antagonist, respectively, on the spectral characteristics of hippocampal theta rhythm elicited by intravenous injection of a anticholinesterase agent, physostigmine. A low dose (16 nmol) of AP5 did not significantly affect EEG recordings, whereas a high dose (50.75 nmol) resulted in significant decreases in phase (-61.8%) at theta frequency, peak theta power (-64.2%), and absolute power of the low-frequency theta band (-67%). These electroencephalographic alterations, which appeared at 50.75 nmol AP5, were amplified following application of massive doses of the drug (121.8 nmol, n = 1, and 162 nmol, n = 1). Amplification, however, was slight and the theta waves remained clearly detectable. On the other hand, the infusion of NMDA resulted in a significant increase in frequency (+25%) of this rhythm, but this effect was completely antagonized by prior local administration of 16 nmol AP5. Our data suggest that the septal NMDA receptors exert subtle modulatory influences on the septohippocampal cells involved in physostigmine-induced theta wave production, which has not been reported elsewhere: tonic with respect to both low-frequency theta band power and theta phase, and phasic with respect to theta frequency. Our data also indicate that the septum may be a sensitive action site for exogenously administered glutamatergic drugs.</description><subject>2-Amino-5-phosphonovalerate - pharmacology</subject><subject>Anesthetics, Intravenous</subject><subject>Animals</subject><subject>Electroencephalography - drug effects</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiology</subject><subject>Male</subject><subject>Microinjections</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Physostigmine</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Septal Nuclei - drug effects</subject><subject>Septal Nuclei - physiology</subject><subject>Theta Rhythm - drug effects</subject><subject>Urethane</subject><issn>0014-4819</issn><issn>1432-1106</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU9v1DAQxS0EKkvhwh3JJw5IBv_JJs6xtBQqteUC52hwxhujxDa2g7R8ab4C3nZpDyNr7N-8edYj5LXg7wXn3YePl5xL2bdSPiEb0SjJhODtU7LhXDSs0aJ_Tl7k_PPQqo6fkBOtRSdbvSF_r3xJkDEWmKnzds0ueBoszTijKe43UvAjNWGJWNxdv5vXAgsUpAlNHQyJwi54lwu9vbk4u-PBl_93F0wyWJwPbMviFHItHyJWwAdnKBg30hzrrnRwsMTZGSjVRKa2KpcJaZz2OeTidlUFmfPjanCkk4sxGFhiHatUAZqmfZmW-gu6JiwTVLhWPjy6P3UiQckvyTMLc8ZXx_OUfL_89O38C7v--vnq_OyaGSVUYdA3o9Qodc_RjsIaM4rW9q0ee6FASbVFKzuLje0bIxsJreg6C8byVioOWp2St_e6MYVfazUxLC4bnOfqKKx5ENuu09uuqeC7e9CkkHNCO8TkFkj7QfDhkO7wmG6F3xxV1x8Ljg_oMU71D02pp1M</recordid><startdate>19960601</startdate><enddate>19960601</enddate><creator>Puma, C</creator><creator>Monmaur, V</creator><creator>Sharif, A</creator><creator>Monmaur, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19960601</creationdate><title>Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats</title><author>Puma, C ; Monmaur, V ; Sharif, A ; Monmaur, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-a94d28e2890efd1fccd16f968d913a3235ef27fe4f94c242a6177facf06230a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>2-Amino-5-phosphonovalerate - pharmacology</topic><topic>Anesthetics, Intravenous</topic><topic>Animals</topic><topic>Electroencephalography - drug effects</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiology</topic><topic>Male</topic><topic>Microinjections</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Physostigmine</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Septal Nuclei - drug effects</topic><topic>Septal Nuclei - physiology</topic><topic>Theta Rhythm - drug effects</topic><topic>Urethane</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Puma, C</creatorcontrib><creatorcontrib>Monmaur, V</creatorcontrib><creatorcontrib>Sharif, A</creatorcontrib><creatorcontrib>Monmaur, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Experimental brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Puma, C</au><au>Monmaur, V</au><au>Sharif, A</au><au>Monmaur, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats</atitle><jtitle>Experimental brain research</jtitle><addtitle>Exp Brain Res</addtitle><date>1996-06-01</date><risdate>1996</risdate><volume>109</volume><issue>3</issue><spage>384</spage><epage>392</epage><pages>384-392</pages><issn>0014-4819</issn><eissn>1432-1106</eissn><abstract>Theta (theta) rhythm may be mediated, at least in part, by a glutamate neurotransmitter. Thus, in the present study, it was hypothesized that the septum glutamatergic NMDA receptor subtype may be involved in the modulation of physostigmine-induced theta rhythm. To test this hypothesis, we analyzed, in the urethane-anesthetized rat, the effects of septum application of NMDA and D-2-amino-5-phosphonopentanoic acid (AP5), selective and competitive NMDA agonist and antagonist, respectively, on the spectral characteristics of hippocampal theta rhythm elicited by intravenous injection of a anticholinesterase agent, physostigmine. A low dose (16 nmol) of AP5 did not significantly affect EEG recordings, whereas a high dose (50.75 nmol) resulted in significant decreases in phase (-61.8%) at theta frequency, peak theta power (-64.2%), and absolute power of the low-frequency theta band (-67%). These electroencephalographic alterations, which appeared at 50.75 nmol AP5, were amplified following application of massive doses of the drug (121.8 nmol, n = 1, and 162 nmol, n = 1). Amplification, however, was slight and the theta waves remained clearly detectable. On the other hand, the infusion of NMDA resulted in a significant increase in frequency (+25%) of this rhythm, but this effect was completely antagonized by prior local administration of 16 nmol AP5. Our data suggest that the septal NMDA receptors exert subtle modulatory influences on the septohippocampal cells involved in physostigmine-induced theta wave production, which has not been reported elsewhere: tonic with respect to both low-frequency theta band power and theta phase, and phasic with respect to theta frequency. Our data also indicate that the septum may be a sensitive action site for exogenously administered glutamatergic drugs.</abstract><cop>Germany</cop><pmid>8817268</pmid><doi>10.1007/BF00229622</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4819
ispartof Experimental brain research, 1996-06, Vol.109 (3), p.384-392
issn 0014-4819
1432-1106
language eng
recordid cdi_proquest_miscellaneous_15778574
source MEDLINE; SpringerLink Journals (MCLS)
subjects 2-Amino-5-phosphonovalerate - pharmacology
Anesthetics, Intravenous
Animals
Electroencephalography - drug effects
Excitatory Amino Acid Agonists - pharmacology
Excitatory Amino Acid Antagonists - pharmacology
Hippocampus - drug effects
Hippocampus - physiology
Male
Microinjections
N-Methylaspartate - pharmacology
Physostigmine
Rats
Rats, Wistar
Septal Nuclei - drug effects
Septal Nuclei - physiology
Theta Rhythm - drug effects
Urethane
title Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intraseptal%20infusion%20of%20selective%20and%20competitive%20glutamate%20receptor%20agonist%20NMDA%20and%20antagonist%20D-2-amino-5-phosphonopentanoic%20acid%20spectral%20implications%20for%20the%20physostigmine-induced%20hippocampal%20theta%20rhythm%20in%20urethane-anesthetized%20rats&rft.jtitle=Experimental%20brain%20research&rft.au=Puma,%20C&rft.date=1996-06-01&rft.volume=109&rft.issue=3&rft.spage=384&rft.epage=392&rft.pages=384-392&rft.issn=0014-4819&rft.eissn=1432-1106&rft_id=info:doi/10.1007/BF00229622&rft_dat=%3Cproquest_cross%3E15778574%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15778574&rft_id=info:pmid/8817268&rfr_iscdi=true